GRIN2A and schizophrenia: Fourth, activation of GRIN2A was prioritized as a mechanism to develop new antipsychotics around, and a clinical case report of schizophrenia in a carrier of a rare LoF variant in GRIN2A provided clues regarding the schizophrenia clinical presentation to target with this pharmacological strategy.